{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:16:41Z","timestamp":1783397801450,"version":"3.54.6"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008883","name":"Nagoya City University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K18835"],"award-info":[{"award-number":["24K18835"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["60-23-0085"],"award-info":[{"award-number":["60-23-0085"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ctro.2026.101192","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:03:49Z","timestamp":1779897829000},"page":"101192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Definitive proton therapy for unresectable trunk soft tissue sarcoma: a single-institution prospective registry-based cohort study"],"prefix":"10.1016","volume":"59","author":[{"given":"Shuou","family":"Sudo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2306-7836","authenticated-orcid":false,"given":"Koichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ogino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8334-1964","authenticated-orcid":false,"given":"Masaki","family":"Sunagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9809-9800","authenticated-orcid":false,"given":"Hiromitsu","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1307-7608","authenticated-orcid":false,"given":"Yukiko","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6762-0015","authenticated-orcid":false,"given":"Toshiyuki","family":"Toshito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5400-5083","authenticated-orcid":false,"given":"Akio","family":"Hiwatashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2026.101192_b0005","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911131","article-title":"Sarcoma treatment in the era of molecular medicine","volume":"12","author":"Gr\u00fcnewald","year":"2020","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ctro.2026.101192_b0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/CCO.0000000000000377","article-title":"Treatment of retroperitoneal sarcoma: current standards and new developments","volume":"29","author":"van Houdt","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0015","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S1470-2045(20)30446-0","article-title":"Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial","volume":"21","author":"Bonvalot","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2022.101814","article-title":"Treatment for local control of retroperitoneal and pelvis sarcomas: a review of the literature","volume":"43","author":"Rust","year":"2022","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0025","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2020.1707","article-title":"Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial: the ANNOUNCE randomized clinical trial","volume":"323","author":"Tap","year":"2020","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ctro.2026.101192_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/20363613221100033","article-title":"Quality of life of patients with soft tissue sarcoma treated with doxorubicin in the ANNOUNCE phase III clinical trial","volume":"14","author":"Van Tine","year":"2022","journal-title":"Rare Tumors"},{"key":"10.1016\/j.ctro.2026.101192_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102620","article-title":"The role of radiation therapy in the management of primary retroperitoneal sarcoma: a systematic review and clinical practice guidelines from the Australia and New Zealand Sarcoma Association","volume":"120","author":"Lawless","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ctro.2026.101192_b0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrclinonc.2017.30","article-title":"Charged-particle therapy in cancer: clinical uses and future perspectives","volume":"14","author":"Durante","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0045","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1002\/cam4.1679","article-title":"Working Group for Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas. Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma","volume":"7","author":"Imai","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.ctro.2026.101192_b0050","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ijrobp.2008.12.019","article-title":"Carbon ion radiotherapy for unresectable retroperitoneal sarcomas","volume":"75","author":"Serizawa","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101192_b0055","unstructured":"Particle Therapy Co-Operative Group. Facilities in Operation. https:\/\/ptcog.site\/index.php\/facilities-in-operation-public [accessed 17 May 2026]."},{"key":"10.1016\/j.ctro.2026.101192_b0060","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijrobp.2017.02.030","article-title":"Particle therapy using protons or carbon ions for unresectable or incompletely resected bone and soft tissue sarcomas of the pelvis","volume":"98","author":"Demizu","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101192_b0065","doi-asserted-by":"crossref","first-page":"S530","DOI":"10.1016\/j.ijrobp.2009.07.1209","article-title":"Particle therapy for bone and soft tissue sarcomas: a retrospective study","volume":"75","author":"Demizu","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101192_b0070","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s13246-016-0456-8","article-title":"A proton therapy system in Nagoya Proton Therapy Center","volume":"39","author":"Toshito","year":"2016","journal-title":"Australas Phys Eng Sci Med"},{"key":"10.1016\/j.ctro.2026.101192_b0075","doi-asserted-by":"crossref","first-page":"189","DOI":"10.14338\/IJPT-D-20-00043.1","article-title":"Spot scanning proton therapy for sinonasal malignant tumors","volume":"8","author":"Nakajima","year":"2021","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.ctro.2026.101192_b0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s13014-018-1144-5","article-title":"Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer","volume":"13","author":"Nakajima","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijrobp.2016.01.017","article-title":"Spot scanning and passive scattering proton therapy: relative biological effectiveness and oxygen enhancement ratio in cultured cells","volume":"95","author":"Iwata","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101192_b0090","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.adro.2019.05.002","article-title":"First-in-human phase 1 study of a nonwoven fabric bioabsorbable spacer for particle therapy: space-making particle therapy (SMPT)","volume":"4","author":"Sasaki","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0095","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2020.02.021","article-title":"Space-making particle therapy for sarcomas derived from the abdominopelvic region","volume":"146","author":"Komatsu","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0100","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ctro.2026.101192_b0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0959-8049(94)90535-5","article-title":"The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life","volume":"30A","author":"Bergman","year":"1994","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctro.2026.101192_b0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","article-title":"Interpreting the significance of changes in health-related quality-of-life scores","volume":"16","author":"Osoba","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ctro.2026.101192_b0120","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1002\/cncr.33139","article-title":"Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: a study from TARPSWG","volume":"126","author":"van Houdt","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.ctro.2026.101192_b0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2022.05.020","article-title":"Long-term outcomes after definitive radiotherapy with modern techniques for unresectable soft tissue sarcoma","volume":"173","author":"Allignet","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0130","article-title":"Hypofractionated radiation therapy for unresectable or metastatic sarcoma lesions","volume":"7","author":"Boyce-Fappiano","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0135","article-title":"Novel definitive hypofractionated accelerated radiation dose-painting (HARD) for unresected soft tissue sarcomas","volume":"9","author":"Bryant","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0140","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ijrobp.2005.03.004","article-title":"Results of radiation therapy for unresected soft-tissue sarcomas","volume":"63","author":"Kepka","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101192_b0145","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/S1470-2045(14)70412-7","article-title":"Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience","volume":"16","author":"Kamada","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2021.08.015","article-title":"Mechanisms and review of clinical evidence of variations in relative biological effectiveness in proton therapy","volume":"112","author":"Paganetti","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101192_b0155","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/cancers14082009","article-title":"A consistent protocol reveals a large heterogeneity in the biological effectiveness of proton and carbon-ion beams for various sarcoma and normal-tissue-derived cell lines","volume":"14","author":"Yagi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ctro.2026.101192_b0160","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijrobp.2013.05.013","article-title":"Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical potential","volume":"87","author":"Giantsoudi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ctro.2026.101192_b0165","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdp298","article-title":"Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent","volume":"21","author":"Anaya","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s13691-024-00661-x","article-title":"Spot scanning proton therapy for unresectable bulky retroperitoneal dedifferentiated liposarcoma: a case report","volume":"13","author":"Nakajima","year":"2024","journal-title":"Int Cancer Conf J"},{"key":"10.1016\/j.ctro.2026.101192_b0175","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1072-7515(01)01024-9","article-title":"Is there a role for incomplete resection in the management of retroperitoneal liposarcomas?","volume":"193","author":"Shibata","year":"2001","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ctro.2026.101192_b0180","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S1470-2045(17)30381-9","article-title":"Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406\/SARC021): an international, multicentre, open-label, randomised phase 3 trial","volume":"18","author":"Tap","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104345","article-title":"Patient-reported outcomes in randomized clinical trials of systemic therapy for advanced soft tissue sarcomas in adults: a systematic review","volume":"197","author":"Roets","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ctro.2026.101192_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.07.003","article-title":"Long-term quality of life after resection of retroperitoneal soft tissue sarcoma","volume":"49","author":"Willis","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctro.2026.101192_b0195","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAT.0000000000000048","article-title":"Grading of soft tissue sarcomas: from histological to molecular assessment","volume":"46","author":"Neuville","year":"2014","journal-title":"Pathology"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082600087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:42:37Z","timestamp":1783395757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082600087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":39,"alternative-id":["S240563082600087X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101192","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitive proton therapy for unresectable trunk soft tissue sarcoma: a single-institution prospective registry-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101192","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101192"}}